GlassScriptPhysician profile
Eric Martin Beckman
NPI 1912132333
$4,972.46
in general payments reported to CMS, 2019-2025
14 companies · $148 in 2025
The $148 reported for 2025 was more than what a typical Periodontics provider received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258 · 2020: $2,807 · 2021: $357 · 2022: $126 · 2023: $914 · 2024: $362 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $906 · Travel and Lodging: $467 · Gift: $50.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $906.12 |
| Travel and Lodging | $467.05 |
| Gift | $50.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $3,221.72 | 2020-2025 | |
| Dentsply Sirona INC | $1,284.45 | 2019-2025 | Implant Dentistry, Astra Tech Implant System, Atlantis |
| Keystone Dental INC. | $183.33 | 2024 | |
| Align Technology, INC. | $84.44 | 2019-2021 | |
| Kulzer, LLC | $30.77 | 2019 | |
| Dentsply Ih INC. | $27.38 | 2019 | |
| Ormco Corporation | $25.13 | 2023 | Creos Xenogain |
| Nobel Biocare USA | $25.12 | 2023 | Nobelactive |
| Orapharma, A Division of Bausch Health US, LLC | $19.87 | 2023 | Ossix Plus, Arestin |
| Geistlich Pharma, North America, INC. | $17.10 | 2020 | |
| Dentsply Ih Ab | $16.98 | 2025 | |
| Biohorizons Implant Systems INC. | $13.53 | 2024 | Biohorizons |
| Zimmer Biomet Holdings, INC. | $12.96 | 2019 | |
| Ace Surgical Supply Co., INC. | $9.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Beckman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.